251 related articles for article (PubMed ID: 28887042)
21. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.
Han J; Liu L; Yue X; Chang J; Shi W; Hua Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):477-83. PubMed ID: 24060341
[TBL] [Abstract][Full Text] [Related]
22. Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases.
Zhao C; Chen X; Yang C; Zang D; Lan X; Liao S; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; Dou QP; Wang X; Liu J
Oncotarget; 2017 Feb; 8(8):13942-13956. PubMed ID: 28086217
[TBL] [Abstract][Full Text] [Related]
23. Hinokitiol Inhibits Migration of A549 Lung Cancer Cells via Suppression of MMPs and Induction of Antioxidant Enzymes and Apoptosis.
Jayakumar T; Liu CH; Wu GY; Lee TY; Manubolu M; Hsieh CY; Yang CH; Sheu JR
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565268
[TBL] [Abstract][Full Text] [Related]
24. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
[TBL] [Abstract][Full Text] [Related]
25. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.
Kumar P; Kumar P; Mandal D; Velayutham R
Front Cell Infect Microbiol; 2022; 12():985178. PubMed ID: 36237424
[TBL] [Abstract][Full Text] [Related]
26. A new gold(I) complex-Au(PPh
Li X; Huang Q; Long H; Zhang P; Su H; Liu J
EBioMedicine; 2019 Jan; 39():159-172. PubMed ID: 30527624
[TBL] [Abstract][Full Text] [Related]
27. Cupriphilic compounds to aid in proteasome inhibition.
Mukherjee S; Sparks R; Metcalf R; Brooks W; Daniel K; Guida WC
Bioorg Med Chem Lett; 2016 Aug; 26(15):3826-9. PubMed ID: 27311892
[TBL] [Abstract][Full Text] [Related]
28. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511
[TBL] [Abstract][Full Text] [Related]
29. Induction of tumor cell apoptosis by taurine Schiff base copper complex is associated with the inhibition of proteasomal activity.
Zhang X; Bi C; Fan Y; Cui Q; Chen D; Xiao Y; Dou QP
Int J Mol Med; 2008 Nov; 22(5):677-82. PubMed ID: 18949390
[TBL] [Abstract][Full Text] [Related]
30. Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells.
Jarvius M; Fryknäs M; D'Arcy P; Sun C; Rickardson L; Gullbo J; Haglund C; Nygren P; Linder S; Larsson R
Biochem Biophys Res Commun; 2013 Feb; 431(2):117-23. PubMed ID: 23318177
[TBL] [Abstract][Full Text] [Related]
31. Metal complexes as inhibitors of the 26S proteasome in tumor cells.
Verani CN
J Inorg Biochem; 2012 Jan; 106(1):59-67. PubMed ID: 22112841
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment.
Xu DC; Yang L; Zhang PQ; Yan D; Xue Q; Huang QT; Li XF; Hao YL; Tang DL; Ping Dou Q; Chen X; Liu JB
Acta Pharmacol Sin; 2022 Aug; 43(8):2128-2138. PubMed ID: 34893683
[TBL] [Abstract][Full Text] [Related]
33. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
Zhang Z; Wang H; Yan M; Wang H; Zhang C
Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
[TBL] [Abstract][Full Text] [Related]
34. Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin.
Yoon MJ; Kang YJ; Lee JA; Kim IY; Kim MA; Lee YS; Park JH; Lee BY; Kim IA; Kim HS; Kim SA; Yoon AR; Yun CO; Kim EY; Lee K; Choi KS
Cell Death Dis; 2014 Mar; 5(3):e1112. PubMed ID: 24625971
[TBL] [Abstract][Full Text] [Related]
35. Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells.
Nehybová T; Šmarda J; Daniel L; Stiborek M; Kanický V; Spasojevič I; Preisler J; Damborský J; Beneš P
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353647
[TBL] [Abstract][Full Text] [Related]
36. Anticancer activity and computational modeling of ternary copper (II) complexes with 3-indolecarboxylic acid and 1,10-phenanthroline.
Zhang Z; Wang H; Wang Q; Yan M; Wang H; Bi C; Sun S; Fan Y
Int J Oncol; 2016 Aug; 49(2):691-9. PubMed ID: 27278680
[TBL] [Abstract][Full Text] [Related]
37. Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells.
Cvek B; Milacic V; Taraba J; Dou QP
J Med Chem; 2008 Oct; 51(20):6256-8. PubMed ID: 18816109
[TBL] [Abstract][Full Text] [Related]
38. Involvement of ALAD-20S Proteasome Complexes in Ubiquitination and Acetylation of Proteasomal α2 Subunits.
Schmitt SM; Neslund-Dudas C; Shen M; Cui C; Mitra B; Dou QP
J Cell Biochem; 2016 Jan; 117(1):144-51. PubMed ID: 26084403
[TBL] [Abstract][Full Text] [Related]
39. Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents.
Chen X; Yang Q; Xiao L; Tang D; Dou QP; Liu J
Cancer Metastasis Rev; 2017 Dec; 36(4):655-668. PubMed ID: 29039082
[TBL] [Abstract][Full Text] [Related]
40. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
